Natera Inc (NAS:NTRA)
$ 124.39 0.95 (0.77%) Market Cap: 15.38 Bil Enterprise Value: 14.82 Bil PE Ratio: 0 PB Ratio: 18.35 GF Score: 72/100

Natera Inc at Canaccord Genuity Growth Conference (Virtual) Transcript

Aug 11, 2021 / 12:30PM GMT
Release Date Price: $102.56 (-2.94%)
Kyle Alexander Mikson
Canaccord Genuity Corp., Research Division - Analyst

Hi. Welcome to the 41st Annual Canaccord Genuity Global Growth Conference. I'm Kyle Mikson, from Life Science Tools & Diagnostics at Canaccord. And we're pleased to have Natera here with us today. Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of company is to change the management of disease worldwide with focus on women's health, oncology and organ health. Representing the company, we have Mike Brophy, CFO. Great to have you here, Mike. Thanks for joining us today.

Michael Brophy
Natera, Inc. - CFO

Thanks for having me, Kyle. Great to be here.

Questions & Answers

Kyle Alexander Mikson
Canaccord Genuity Corp., Research Division - Analyst

Sure. So Mike, just set the stage. So let's start with the 2Q results. So Natera announced last week results ahead of your preliminary numbers announced July 19, and you increased your revenue guidance to $620 million, which is impressive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot